Craze in Netherlands for Daeyang Medical’s obesity treatment device Coolipo Twin

- Excellent in reducing adipose tissue in neuromuscle and around bones

- New technology for fat control – low-temperature lypolysis system

WONJU--(뉴스와이어)--Daeyang Medical (CEO Yun Il Yong)’s Coolipo Twin is creating a sensation in Europe, especially in Netherlands.

Daeyang Medical said its popular Coolipo Twin, which is now settling down in the world market, is excellent in reducing in reducing adipose tissue in neuromuscle and around bones. It is especially effective in body parts with more fat.

Coolipo Twin is the new method of fat control proposed by Daeyang Medical, an obesity treatment device developer, and it adopted the low-temperature lipolysis system. The new technology low-temperature lipolysis system induces fat breakdown by freezing fat, the cause of obesity, based on the fact that the skin grease is sensitive to cold.

Coolipo Twin treatment does not require needles or anesthesia, and can be done in minimum time. It removes non-invasive fat in body and reduces 20 to 23 percent of total fat on the average. Coolipo Twin is not a weight loss device, but with a dietary therapy and regular exercise, it is more effective in fat reduction than general liposuction devices. In addition, Coolipo Twin can be used as a liposuction cooler.

Since its establishment, Daeyang Medical has been developing products consistently and their products are now internationally recognized in the medical device field. Already has its technical skills and effectiveness approved in European countries, Coolipo Twin will become Daeyang Medical’s new best seller.

More information on Coolipo Twin is available on the website http://cryospecialist.nl

대양의료기 개요
대양의료기는 새로운 개념의 미용 관련 의료기기를 생산하는 기업이다.

Coolipo Twin: http://cryospecialist.nl

연락처

Daeyang Medical Co., Ltd.
+82-33-747-4465~6

국내 최대 배포망으로 보도자료를 배포하세요